Evidence map›Paper›PMID 29489822›Full record

ArticlePLoS computational biology2018

Ligand-induced perturbation of the HIF-2α:ARNT dimer dynamics.

Stefano Motta, Claudia Minici, Dario Corrada, Laura Bonati, Alessandro Pandini

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Allosteric Network Analysis Toolkit for Single-Domain Phosphoproteins.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Review
  5. TCDD-Induced Allosteric Perturbation of the AhR:ARNT Binding to DNA.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Oxygen-sensing mechanisms in development and tissue repair.Development (Cambridge, England) · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Stefano MottaDepartment of Earth and Environmental Sciences, University of Milano-Bicocca, Milan, Italy.
Claudia MiniciDepartment of Immunology, Transplantation, and Infectious Diseases, DIBIT Fondazione San Raffaele, Milan, Italy.ORCID 0000-0002-8350-484X
Dario CorradaDepartment of Earth and Environmental Sciences, University of Milano-Bicocca, Milan, Italy.ORCID 0000-0001-7390-9520
Laura BonatiDepartment of Earth and Environmental Sciences, University of Milano-Bicocca, Milan, Italy.ORCID 0000-0003-3028-0368
Alessandro PandiniDepartment of Computer Science-Synthetic Biology Theme, Brunel University London, Uxbridge, United Kingdom.ORCID 0000-0002-4158-233X
University of Milano-Bicocca · ITThomas Young Centre · GBVita-Salute San Raffaele University · IT

Funding

RECOMBINANT DETECTION SYSTEMS FOR DIOXIN LIKE CHEMICALSR01ES007685 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI DENISON, MICHAEL STEVEN · 1995 to 2019
$4.7M
NIEHS NIH HHS R01 ES007685NIH HHS R01ES007685
6 · The paper itself

Abstract

Hypoxia inducible factors (HIFs) are transcription factors belonging to the basic helix-loop-helix PER-ARNT-SIM (bHLH-PAS) protein family with a role in sensing oxygen levels in the cell. Under hypoxia, the HIF-α degradation pathway is blocked and dimerization with the aryl hydrocarbon receptor nuclear translocator (ARNT) makes HIF-α transcriptionally active. Due to the common hypoxic environment of tumors, inhibition of this mechanism by destabilization of HIF-α:ARNT dimerization has been proposed as a promising therapeutic strategy. Following the discovery of a druggable cavity within the PAS-B domain of HIF-2α, research efforts have been directed to identify artificial ligands that can impair heterodimerization. Although the crystallographic structures of the HIF-2α:ARNT complex have elucidated the dimer architecture and the 0X3-inhibitor placement within the HIF-2α PAS-B, unveiling the inhibition mechanism requires investigation of how ligand-induced perturbations could dynamically propagate through the structure and affect dimerization. To this end, we compared evolutionary features, intrinsic dynamics and energetic properties of the dimerization interfaces of HIF-2α:ARNT in both the apo and holo forms. Residue conservation analysis highlighted inter-domain connecting elements that have a role in dimerization. Analysis of domain contributions to the dimerization energy demonstrated the importance of bHLH and PAS-A of both partners and of HIF-2α PAS-B domain in dimer stabilization. Among quaternary structure oscillations revealed by Molecular Dynamics simulations, the hinge-bending motion of the ARNT PAS-B domain around the flexible PAS-A/PAS-B linker supports a general model for ARNT dimerization in different heterodimers. Comparison of the HIF-2α:ARNT dynamics in the apo and 0X3-bound forms indicated a model of inhibition where the HIF-2α-PAS-B interfaces are destabilised as a result of water-bridged ligand-protein interactions and these local effects allosterically propagate to perturb the correlated motions of the domains and inter-domain communication. These findings will guide the design of improved inhibitors to contrast cell survival in tumor masses.

Indexed as

Molecular Dynamics SimulationProtein DomainsAnimalsAryl Hydrocarbon Receptor Nuclear TranslocatorBasic Helix-Loop-Helix ProteinsCrystallography, X-RayEndothelial PAS Domain-Containing Protein 1LigandsMiceMutationOscillometryOxygenProtein BindingProtein MultimerizationThermodynamicsTranscription, GeneticAryl Hydrocarbon Receptor Nuclear TranslocatorBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1LigandsOxygenWater

Identifiers

PMID29489822
PMCPMC5847239
OpenAlexW2789352221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.